Neonatology pp 1785-1792 | Cite as

Neonatal Viral Infections: Enteroviruses and Respiratory Syncytial Virus

  • Paolo ManzoniEmail author
  • Davide Montin
  • Elena Tavella
  • Pier Angelo Tovo
Reference work entry


The detection and identification of viral infections in newborns have been greatly improved by the recent development of rapid and highly sensitive diagnostic methods, particularly polymerase chain reaction (PCR) techniques. Most common clinical presentations of viral infection are sepsis-like illness, prolonged seizures, respiratory disease, gastrointestinal disease, and NEC-like syndrome. Enterovirus and Parechovirus (EV/PeV) infections are the most frequently diagnosed infections in newborns and are responsible for the highest mortality. These infections can lead to myocarditis, meningitis, and encephalitis and may cause severe cardiac and neurological sequelae. Respiratory syncytial virus (RSV) ranks second as incidence, especially during winter. RSV may cause a severe bronchiolitis or pneumonia especially in preterm infants. Palivizumab is a monoclonal antibody which may reduce the burden of RSV-related disease. Palivizumab prophylaxis is recommended in premature infants below 35 weeks of gestational age, in infants with bronchopulmonary dysplasia (BPD), and in infants with severe congenital heart disease in the first year of life.


  1. Abedi GR, Watson JT, Pham H et al (2015) Enterovirus and human parechovirus surveillance – United States, 2009–2013. MMWR Morb Mortal Wkly Rep 64:940–943CrossRefGoogle Scholar
  2. Abzug MJ (2004) Presentation, diagnosis, and management of enterovirus infections in neonates. Paediatr Drugs 6:1–10CrossRefGoogle Scholar
  3. Baraldi E, Lanari M, Manzoni P et al (2014) Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants. Ital J Pediatr 40:65CrossRefGoogle Scholar
  4. Blanken MO, Rovers MM, Bont L, Dutch RSV Neonatal Network (2014) Respiratory syncytial virus and recurrent wheeze. N Engl J Med 369:782–783Google Scholar
  5. Boivin G, Abed Y, Boucher FD (2005) Human parechovirus 3 and neonatal infections. Emerg Infect Dis 11:103–105CrossRefGoogle Scholar
  6. Bollani L, Baraldi E, Chirico G et al (2015) Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV). Ital J Pediatr 41:97CrossRefGoogle Scholar
  7. Chávez-Bueno S, Mejías A, Merryman RA et al (2007) Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J 26:1089–1093CrossRefGoogle Scholar
  8. Cherry JD (2006) Enterovirus and parechovirus infections in: infectious diseases of the fetus and newborn infant, 6th edn. Elsevier Saunders, Philadelphia, pp 783–822CrossRefGoogle Scholar
  9. Cilla A, Arnaez J, Suarez J et al (2015) Human parechovirus and enterovirus in neonates: distinct infections with overlapping features. Early Hum Dev 91:475–478CrossRefGoogle Scholar
  10. Civardi E, Tzialla C, Baldanti F et al (2013) Viral outbreaks in neonatal intensive care units: what we do not know. Am J Infect Control 41:854–856CrossRefGoogle Scholar
  11. Esposito S, Janette R-L, Beatrice A et al (2014) Pediatric parechovirus infections. J Clin Virol 60:84–89CrossRefGoogle Scholar
  12. Farzin A, Saha SK, Baqui AH et al (2015) Population-based incidence and etiology of community-acquired neonatal viral infections in Bangladesh: a community-based and hospital-based surveillance study. Pediatr Infect Dis J 34:706–711CrossRefGoogle Scholar
  13. Fjaerli H-O, Farstad T, Rød G et al (2005) Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway. BMC Pediatr 5:31CrossRefGoogle Scholar
  14. Freund MW, Kleinveld G, Krediet TG et al (2010) Prognosis for neonates with enterovirus myocarditis. Arch Dis Child Fetal Neonatal Ed 95:F206–F212CrossRefGoogle Scholar
  15. Fu Y-C, Chi C-S, Jan S-L et al (2003) Pulmonary edema of enterovirus 71 encephalomyelitis is associated with left ventricular failure: implications for treatment. Pediatr Pulmonol 35:263–268CrossRefGoogle Scholar
  16. Guerguerian A-M, Anne-Marie G, Marie G et al (1999) Ribavirin in ventilated respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 160:829–834CrossRefGoogle Scholar
  17. Hagan JE, Wassilak SG, Craig AS et al (2015) Progress toward polio eradication – worldwide, 2014–2015. MMWR Morb Mortal Wkly Rep 64:527–531PubMedPubMedCentralGoogle Scholar
  18. Harvala H, Heli H, Nigel M et al (2011) Comparison of human parechovirus and enterovirus detection frequencies in cerebrospinal fluid samples collected over a 5-year period in Edinburgh: HPeV type 3 identified as the most common picornavirus type. J Med Virol 83:889–896CrossRefGoogle Scholar
  19. Hostetler MA, Suara RO, Denison MR (2002) Unilateral facial paralysis occurring in an infant with enteroviral otitis media and aseptic meningitis. J Emerg Med 22:267–271CrossRefGoogle Scholar
  20. Khatami A, McMullan BJ, Webber M et al (2014) Sepsis-like disease in infants due to human parechovirus type 3 during an outbreak in Australia. Clin Infect Dis 60:228–236CrossRefGoogle Scholar
  21. Khetsuriani N, Nino K, Ashley L et al (2006) Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983–2003. Pediatr Infect Dis J 25:889–893CrossRefGoogle Scholar
  22. Krous HF, Ferandos C, Masoumi H et al (2009) Myocardial inflammation, cellular death, and viral detection in sudden infant death caused by SIDS, suffocation, or myocarditis. Pediatr Res 66:17–21CrossRefGoogle Scholar
  23. Piralla A, Furione M, Rovida F et al (2012) Human parechovirus infections in patients admitted to hospital in Northern Italy, 2008–2010. J Med Virol 84:686–690CrossRefGoogle Scholar
  24. Piralla A, Mariani B, Stronati M et al (2014) Human enterovirus and parechovirus infections in newborns with sepsis-like illness and neurological disorders. Early Hum Dev 90(S1):S75–S77CrossRefGoogle Scholar
  25. Ronchi A, Michelow IC, Chapin KC et al (2014) Viral respiratory tract infections in the neonatal intensive care unit: the VIRIoN-I study. J Pediatr 165:690–696CrossRefGoogle Scholar
  26. Rorabaugh ML, Berlin LE, Heldrich F et al (1993) Aseptic meningitis in infants younger than 2 years of age: acute illness and neurologic complications. Pediatrics 92:206–211PubMedGoogle Scholar
  27. Schlapbach LJ, Joerg E, Christian B et al (2013) Enteroviral myocarditis in neonates. J Paediatr Child Health 49:E451–E454CrossRefGoogle Scholar
  28. Simões EAF, Carbonell-Estrany X, Fullarton JR et al (2008) A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33–35 weeks of gestational age, based on data from the Spanish FLIP Study. Respir Res 9:78CrossRefGoogle Scholar
  29. Verboon-Maciolek MA, Krediet TG, Gerards LJ et al (2005) Clinical and epidemiologic characteristics of viral infections in a neonatal intensive care unit during a 12-year period. Pediatr Infect Dis J 24:901–904CrossRefGoogle Scholar
  30. Verboon-Maciolek MA, Krediet TG, Gerards LJ et al (2008a) Severe neonatal parechovirus infection and similarity with enterovirus infection. Pediatr Infect Dis J 27:241–245CrossRefGoogle Scholar
  31. Verboon-Maciolek MA, Utrecht FG, Cowan F et al (2008b) White matter damage in neonatal enterovirus meningoencephalitis. Neurology 71:536CrossRefGoogle Scholar
  32. Verboon-Maciolek MA, Floris G, Hahn CD et al (2008c) Human parechovirus causes encephalitis with white matter injury in neonates. Ann Neurol 64:266–273CrossRefGoogle Scholar
  33. Vollbach S, Silke V, Andreas M et al (2015) Prevalence, type and concentration of human enterovirus and parechovirus in cerebrospinal fluid samples of pediatric patients over a 10-year period: a retrospective study. Virol J 12:199CrossRefGoogle Scholar
  34. Wu T, Fan X-P, Wang et al (2014) Enterovirus infections are associated with white matter damage in neonates. J Paediatr Child Health 50:817–822CrossRefGoogle Scholar
  35. Yen M-H, Huang Y-C, Chen M-C et al (2015) Effect of intravenous immunoglobulin for neonates with severe enteroviral infections with emphasis on the timing of administration. J Clin Virol 64:92–96CrossRefGoogle Scholar
  36. Zhang Y-F, Deng H-L, Fu J et al (2016) Pancreatitis in hand-foot-and-mouth disease caused by enterovirus 71. World J Gastroenterol 22:2149–2152CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Paolo Manzoni
    • 1
    Email author
  • Davide Montin
    • 1
    • 2
  • Elena Tavella
    • 1
  • Pier Angelo Tovo
    • 3
  1. 1.Division of Neonatology, Department of Obstetrics and NeonatologyAOU Città della Salute e della ScienzaTurinItaly
  2. 2.Department of PediatricsUniversity of TurinTurinItaly
  3. 3.Department of PediatricsUniversity of Turin, Regina Margherita Childrens Hospital, AOU Città della Salute e della Scienza di TorinoTurinItaly

Personalised recommendations